Skip to main content
. 2017 Apr 29;8(33):54592–54603. doi: 10.18632/oncotarget.17523

Table 3. Used antibodies and positivity thresholds for immunohistochemistry.

Antigen Antibody Dilution Stratification of staining results
PSCA MB1[4] 5 ng/μl 1-9% weak positiv; >9% strong positiv
Ki-67 MIB-1 (DAKO) 1:50 0-9%, 10-20%, >20%
estrogen receptor SP1 (Ventana) prediluted by manufacturer threshold for positivity: >1%
progesterone receptor 1E2 (Ventana) prediluted by manufacturer threshold for positivity: >1%
HER-2/neu A0485 (DAKO) 1:800 negative: IRS 0, 1+, 2+ without Her-2/neugene amplificationpositive: IRS 2+ with Her-2/neu geneamplification, IRS 3+; [51]